Abstract | AIM: To investigate the clinical significance of Bcl-xL gene in the pathogenesis of human colon carcinoma. METHODS: Fifty-six pair tissue samples from patients with colon cancer were collected, and protein level of the Bcl-xL gene was measured by immunohistochemistry method. The correlation of Bcl-xL expression with clinical index was evaluated. After human colon cancer cell line HT29 was transfected with Bcl-xL small interfering RNA ( siRNA), the anchorage-independent growth of cancer cells was detected by colony formation in soft agar and invasion ability of cancer cells was determined by a transwell model. RESULTS: The Bcl-xL expression was higher in cancerous tissue samples than in normal tissue samples (38.78 +/-11.36 vs 0.89 +/- 0.35, P < 0.001), and was associated with the pathological grade, lymph node metastasis and Duke's stage of colorectal carcinoma. Transfection with Bcl-xL siRNA inhibited the colony formation and invasion ability of human colon cancer cell line HT29 in vitro. CONCLUSION:
|
Authors | You-Li Zhang, Li-Qun Pang, Ying Wu, Xiao-Yan Wang, Chong-Qiang Wang, Yu Fan |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 14
Issue 19
Pg. 3069-73
(May 21 2008)
ISSN: 1007-9327 [Print] United States |
PMID | 18494061
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- BCL2L1 protein, human
- RNA, Small Interfering
- bcl-X Protein
|
Topics |
- Carcinoma
(genetics, metabolism, pathology)
- Cell Movement
- Cell Proliferation
- Colonic Neoplasms
(genetics, metabolism, pathology)
- Female
- HT29 Cells
- Humans
- Immunohistochemistry
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Staging
- RNA Interference
- RNA, Small Interfering
(metabolism)
- Time Factors
- Transfection
- bcl-X Protein
(genetics, metabolism)
|